News

InvestorsHub on MSN35m
Apellis shares jump 12% following FDA approval of first-ever C3G treatment
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) saw its stock soar 12% after the U.S. Food and Drug Administration (FDA) granted ...
Is C3.ai the Enterprise AI Stock to Watch?
Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...